Sterling Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4K Sell
94
-73
-44% -$2.14K ﹤0.01% 2807
2026
Q1
$4.12K Hold
167
﹤0.01% 2813
2025
Q4
$2.82K Buy
167
+105
+169% +$1.85K ﹤0.01% 3020
2025
Q3
$1.35K Hold
62
﹤0.01% 3040
2025
Q2
$884 Buy
+62
New +$980 ﹤0.01% 3079

Other funds holding ETON

Sterling Capital Management's ETON Position: Q2 2026 in Review

Sterling Capital Management reduced its Eton Pharmaceutcials (ETON) stake by 44% in Q2 2026, selling an estimated $2.14K and leaving 94 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2807.

Sterling Capital Management first reported a position in ETON in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.12K in Q1 2026. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Sterling Capital Management held 94 shares of Eton Pharmaceutcials worth $3.4K as of Q2 2026.
  • Sterling Capital Management sold 73 Eton Pharmaceutcials shares in Q2 2026, an estimated $2.14K.
  • Eton Pharmaceutcials made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2807 holding.
  • Sterling Capital Management first reported a position in Eton Pharmaceutcials in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Eton Pharmaceutcials position peaked at $4.12K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.